111 related articles for article (PubMed ID: 3189300)
1. Transient ischemic attack in a patient with congenital protein-C deficiency during treatment with stanozolol.
De Stefano V; Leone G; Teofili L; Ferrelli R; Pollari G; Antonini V; Bizzi B
Am J Hematol; 1988 Oct; 29(2):120-1. PubMed ID: 3189300
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hereditary protein C deficiency with stanozolol.
Broekmans AW; Conard J; van Weyenberg RG; Horellou MH; Kluft C; Bertina RM
Thromb Haemost; 1987 Feb; 57(1):20-4. PubMed ID: 3590078
[TBL] [Abstract][Full Text] [Related]
3. Arterial thrombosis as clinical manifestation of congenital protein C deficiency.
De Stefano V; Leone G; Micalizzi P; Teofili L; Falappa PG; Pollari G; Bizzi B
Ann Hematol; 1991 May; 62(5):180-3. PubMed ID: 2049465
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic antithrombotic therapy with stanozolol in patients with familial antithrombin III deficiency.
Winter JH; Fenech A; Bennett B; Douglas AS
Br J Haematol; 1984 Jul; 57(3):527-37. PubMed ID: 6743570
[TBL] [Abstract][Full Text] [Related]
5. Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozolol.
Kluft C; Bertina RM; Preston FE; Malia RG; Blamey SL; Lowe GD; Forbes CD
Thromb Res; 1984 Feb; 33(3):297-304. PubMed ID: 6546815
[TBL] [Abstract][Full Text] [Related]
6. [Congenital protein C deficiency and thromboembolic diseases].
Schwieder G; Vieregge P; Wiedemann G; Wagner T
Dtsch Med Wochenschr; 1987 Mar; 112(11):425-8. PubMed ID: 3816591
[TBL] [Abstract][Full Text] [Related]
7. Neurological complications in children with protein C deficiency.
van Kuijck MA; Rotteveel JJ; van Oostrom CG; Novakova I
Neuropediatrics; 1994 Feb; 25(1):16-9. PubMed ID: 8208345
[TBL] [Abstract][Full Text] [Related]
8. Familial coagulation-inhibiting and fibrinolytic protein deficiencies in juvenile transient ischaemic attacks.
De Lucia D; Renis V; Belli A; Conte M; Di Mauro C; Tortora V; d'Alessio D; Nina PP; Franco A; Schisano G; Papa ML
J Neurosurg Sci; 1996 Mar; 40(1):25-35. PubMed ID: 8913958
[TBL] [Abstract][Full Text] [Related]
9. Effects of oral stanozolol used in the prevention of postoperative deep vein thrombosis on fibrinolytic activity.
Sue-Ling HM; Davies JA; Prentice CR; Verheijen JH; Kluft C
Thromb Haemost; 1985 Feb; 53(1):141-2. PubMed ID: 3873118
[TBL] [Abstract][Full Text] [Related]
10. Protein C deficiency presenting as deep venous thrombosis in pregnancy. Case report.
Morrison AE; Walker ID; Black WP
Br J Obstet Gynaecol; 1988 Oct; 95(10):1077-80. PubMed ID: 3056500
[No Abstract] [Full Text] [Related]
11. Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman.
De Stefano V; Teofili L; Rocca B; Nicoletti G; Leone G; Bizzi B
Br J Haematol; 1989 Dec; 73(4):565-6. PubMed ID: 2611143
[No Abstract] [Full Text] [Related]
12. Does stanozolol prevent venous ulceration?
Drug Ther Bull; 1985 Nov; 23(23):91-2. PubMed ID: 3905324
[No Abstract] [Full Text] [Related]
13. [Effect of danazol on heterozygous c protein coagulation deficiency exacerbated by Salmonella typhi sepsis].
Lobato-Mendizábal E; Ruiz-Argüelles GJ; Toquero-Franco O
Bol Med Hosp Infant Mex; 1989 May; 46(5):343-5. PubMed ID: 2757777
[TBL] [Abstract][Full Text] [Related]
14. Stanozolol causes rapid pain relief and healing of cutaneous ulcers caused by cryofibrinogenemia.
Kirsner RS; Eaglstein WH; Katz MH; Kerdel FA; Falanga V
J Am Acad Dermatol; 1993 Jan; 28(1):71-4. PubMed ID: 8425973
[TBL] [Abstract][Full Text] [Related]
15. Treatment of lipodermatosclerosis with oxandrolone in a patient with stanozolol-induced hepatotoxicity.
Segal S; Cooper J; Bolognia J
J Am Acad Dermatol; 2000 Sep; 43(3):558-9. PubMed ID: 10954677
[No Abstract] [Full Text] [Related]
16. The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol.
Belch JJ; Madhok R; McArdle B; McLaughlin K; Kluft C; Forbes CD; Sturrock RD
Q J Med; 1986 Jan; 58(225):19-27. PubMed ID: 3517926
[TBL] [Abstract][Full Text] [Related]
17. Protein C antigen levels in major abdominal surgery: relationships to deep vein thrombosis, malignancy and treatment with stanozolol.
Blamey SL; Lowe GD; Bertina RM; Kluft C; Sue-Ling HM; Davies JA; Forbes CD
Thromb Haemost; 1985 Oct; 54(3):622-5. PubMed ID: 3911479
[TBL] [Abstract][Full Text] [Related]
18. Stanozolol as a novel therapeutic agent in dermatology.
Helfman T; Falanga V
J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):254-8. PubMed ID: 7622653
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic recurrent superficial thrombophlebitis: treatment with fibrinolytic enhancement.
Jarrett PE; Morland M; Browse NL
Br Med J; 1977 Apr; 1(6066):933-4. PubMed ID: 856391
[TBL] [Abstract][Full Text] [Related]
20. Congenital deficiencies of anticoagulant proteins (antithrombin III and protein C).
Mannucci PM; Tripodi A; Mari D
Haematologica; 1984; 69(6):730-46. PubMed ID: 6441751
[No Abstract] [Full Text] [Related]
[Next] [New Search]
